PSUSA/00001913/202405

PSUSA/00010693/202404

Human medicines European public assessment report (EPAR): Renagel, sevelamer, Date of authorisation: 28/01/2000, Revision: 38, Status: Authorised

Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests

Human medicines European public assessment report (EPAR): Levodopa/Carbidopa/Entacapone Orion, levodopa,carbidopa,entacapone, Date of authorisation: 23/08/2011, Revision: 15, Status: Authorised

CHMP and Rapporteurs' assessment report template on Similarity Rev. 01.25

Human medicines European public assessment report (EPAR): Skycovion, GBP510, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Masitinib AB Science, masitinib, Date of refusal: 19/12/2024, Status: Refused

Accelerating Clinical Trials in the EU (ACT EU)

Appendix 1: Acceptable intakes established for N-nitrosamines